Oral sensitization to food proteins: a Brown Norway rat model.
BACKGROUND
Although several in vivo antigenicity assays using parenteral immunization are operational, no adequate enteral sensitization models are available to study food allergy and allergenicity of food proteins.


OBJECTIVE
This paper describes the development of an enteral model for food allergy research in the Brown Norway (BN) rat.


METHODS
The animals were exposed to ovalbumin either ad libitum via the drinking water (0.002 to 20 mg/mL) continuously for 6 weeks or by gavage (1 mg/mL per rat). Gavage dosing was performed either daily, twice a week, once a week or once every 2 weeks during a period of 6 weeks. No adjuvants were used during the sensitization studies.


RESULTS
After intra-gastric administration of ovalbumin once or twice a week or once every two weeks, no or only a very low frequency of ovalbumin-specific antibody responses were detected. Daily intra-gastric dosing with ovalbumin resulted in antigen-specific IgG as well as IgE responses in almost all animals tested. Upon ad libitum exposure, ovalbumin-specific IgG but no ovalbumin-specific IgE was detected. The cellular response was examined by determination of delayed-type hypersensitivity (DTH) reactions in the animals dosed by daily gavage and in the ad libitum exposed rats. Both sensitization protocols sensitized for DTH. The response was most pronounced in ad libitum exposed rats at day 28 of exposure.


CONCLUSIONS
These studies show that the BN rat may provide a suitable animal model for inducing specific IgG and IgE responses as well as specific T-cell mediated hypersensitivity (DTH) to ovalbumin upon exposure via the enteral route without the use of adjuvants.
Knippels
L M
LM
TNO Nutrition and Food Research Institute, Zeist, The Netherlands.
Penninks
A H
AH
Spanhaak
S
S
Houben
G F
GF
D000284:Administration, Oral; D000818:Animals; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D005512:Food Hypersensitivity; D006968:Hypersensitivity, Delayed; D007073:Immunoglobulin E / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D010047:Ovalbumin / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D010323:Passive Cutaneous Anaphylaxis; D051381:Rats; D011914:Rats, Inbred BN
D007074:Immunoglobulin G; D007073:Immunoglobulin E; D010047:Ovalbumin